Eugene Helsel
General Counsel at Artiva Biotherapeutics, Inc.
Profile
Eugene Helsel is currently the Vice President of Regulatory Affairs & Quality at Artiva Biotherapeutics, Inc. Prior to this, he worked as the Senior Director of Regulatory Affairs at Capricor, Inc. and as the Executive Director of Regulatory Affairs & Quality at Fate Therapeutics, Inc. He received his undergraduate degree from National University and the University of California San Diego.
Eugene Helsel active positions
| Companies | Position | Start |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | General Counsel | - |
Former positions of Eugene Helsel
| Companies | Position | End |
|---|---|---|
| FATE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Corporate Officer/Principal | - |
Training of Eugene Helsel
| University of California San Diego | Undergraduate Degree |
| National University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Stock Market
- Insiders
- Eugene Helsel
